Country Reports

Clinical trial regulation in Mexico

Regulatory improvements make Mexico an appealing destination for clinical trials outsourcing

The impact of Hollande's healthcare reforms in France

A tougher environment for pharma, with market access and regulatory challenges

Infographic: Type 2 diabetes in Brazil

Key facts about the chronic condition's impact in the emerging market

Brazil: Patient access and education in type 2 diabetes

As the prevalence of diabetes increases in Brazil, the healthcare system needs to respond

Unfolding the biosimilar landscape in Latin America

Cost containment and safety concerns mean an ongoing tussle between payers and regulators, with the latter gaining the upper hand

Current development and marketing of biosimilar monoclonal antibodies in Latin America

An in-depth table of biosimilar products in the region

Opportunities in the medical devices sector in India

Growing medical tourism, a burgeoning hospital sector and increased patient affluence make India an attractive prospect for medical device companies looking for partnerships

Partial privatisation shakes up pharma market in Spain

Pharma struggling with unpaid drug bills, price cuts and cost-containment measures amid upheaval of healthcare system

China: Engagement strategies

As China grows apace, digital is increasingly being used to engage both customers and patients

An eye towards the biobetter in South Korea

It is critical that the competitive strategies of global pharma companies take into consideration the capabilities and experience of emerging South Korean firms

Biosimilars in China

Tipping the balance: risks and opportunities in biosimilars

Positive prospects for pharma in Latin America

Latin America offers a healthy proposition for investors when compared to mature, stalling markets with poor growth predictions

Tough times for pharma in Portugal

Industry body warns of paucity of essential medicines and damage to industry reputation

Drug pricing in Ireland

Sustained pressure on healthcare spending, combined with the continued impact of patent expiries, could thwart the pharma industry in Ireland

Under threat: The pharma industry in Spain

The Eurozone crisis threatens healthcare and pharma opportunities

Market access opportunities in China

Pope Woodhead highlights the key steps to accessing the high-value therapeutics market in China

Revolution or evolution: is it the end of SMR and ASMR in France?

As Marisol Touraine aims to cut healthcare spending and patients and doctors push for innovative drugs to be priced against the standard of care, what lies in store for pharma?

Country report: The healthcare market in France

Affected for the past four years by a series of major issues, the French pharma industry is seeking new areas of significant growth

Country report: The healthcare market in Brazil

Brazil is the number one pharmaceutical market in Latin America and third in America, with a market value of $25.60bn in 2011

Country report: The healthcare market in South Korea

The South Korean pharmaceutical market has had consistent double-digit growth for five years and is considered the fastest-growing developed country by IMS Health